RAVENSBURG, Germany--(BUSINESS WIRE)--Jan 15, 2026--
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has completed several important steps in the ongoing development and upcoming launch of V-OVS ®next.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115544951/en/
Developed from extensive market feedback, this new closure system will feature several important updates: intuitive handling, innovative functionality and a premium design, that fits a wide range of syringe formats. Together these advances will further enhance the protection and usability V-OVS ®next offers for applications across a broad range of markets such as ophthalmology, aesthetic injectables, diluents, and biologics. Unveiled at PharmaPack 2025 and met with significant industry interest, the closure has since taken multiple key steps toward commercial readiness in 2027.
After a robust, multi-cycle development process, Vetter has finalized the design of V-OVS ®next and initiated industrialization. As part of that process, Vetter will provide its primary syringe glass suppliers with NFHU materials for further implementation and testing across a range of syringe formats.
“With the first biopharma customers already giving positive feedback, we’re excited to see market uptake by some glass suppliers,” says Lars Hahn, Senior Vice President Global Sales Organization at Vetter. “We’ve already had successful conversations with multiple value chain partners and received consistently encouraging responses that reinforce our confidence in this launch.”
Vetter has completed two more important verification steps of its own: After successfully completing a first Human Factors study earlier in 2025, a second Human Factors study and a key Functional Study have both delivered positive results for V-OVS ®next.
While the earlier evaluation focused on product and user-related feedback, the second Human Factors study additionally included a use related risk analysis to confirm that V-OVS ®next enables safe and effective handling. After evaluating the closure system’s usability and comparing it with the original V-OVS ® closure, study participants confirmed: V-OVS ®next is a user-friendly design that offers an enhanced user experience with a differentiating look and feel.
In addition, Vetter evaluated the structural performance of V-OVS ®next during manufacturing and handling. First tests demonstrated that V-OVS ®next further improves upon the performance of the existing V-OVS ®, supports intuitive handling, and reduces the likelihood of misuse.
“Our goal was to combine safety, usability, and design in a way that truly benefits the user of the system,” says Dr. Claus Feussner, Senior Vice President Development Service at Vetter. “The positive results from both usability and performance evaluations confirm that V-OVS ®next delivers on these objectives.”
With these milestones achieved, Vetter will continue to advance V-OVS ®next down its pathway toward launch. Industrialization is on track and commercialization is scheduled for 2027. Post-launch, Vetter will continue to offer both V-OVS ® and V-OVS ®next, expanding its portfolio of solutions for customers’ syringe-based products. Furthermore, V-OVS ® and V-OVS ®next share the same contact materials and a range of industry standard tip cap rubber formulations, making it easy to upgrade to the new system as a lifecycle measure for existing drugs or a differentiating factor for new drugs.
Find the Vetter press kit and more background information here.
About Vetter
Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the independent pharmaceutical service provider is also present in the Asia-Pacific markets of Japan, China, South Korea and Singapore with sales locations. Around the world, small and large renowned pharma and biotech companies rely on the decades of experience, high quality, modern technologies, reliability, and commitment of its more than 7,300 employees. In close partnership with its customers, the Vetter team supplies patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. With innovative solutions, Vetter develops prefilled drug-delivery systems together with its customers to continuously improve patient safety, comfort, and compliance. The company is an industry pioneer in sustainability and a socially and ethically responsible corporate citizen. The CDMO is a member of the UN Global Compact and Science Based Target initiative (SBTi) and received platinum status in the renowned EcoVadis ranking. Multiple awards such as the CDMO Leadership Awards, Frost & Sullivan Customer Value Leadership Award and the recognition as Best Managed Company emphasize Vetter’s commitment to sustainable business. Founded in Ravensburg in 1950, the company remains family-owned to this day. For more information, visit www.vetter-pharma.com and follow Vetter on LinkedIn.
V-OVS® next mounted on a syringe
MINNEAPOLIS (AP) — President Donald Trump on Thursday threatened to invoke the Insurrection Act and deploy troops to quell persistent protests against the federal officers sent to Minneapolis to enforce his administration's massive immigration crackdown.
The president's threat comes a day after a federal immigration officer shot and wounded a Minneapolis man who had attacked the officer with a shovel and broom handle. That shooting further heightened the fear and anger radiating across the Minnesota city since an Immigration and Customs Enforcement agent fatally shot a Renee Good in the head.
Trump has repeatedly threatened to invoke the rarely used federal law to deploy the U.S. military or federalize the National Guard for domestic law enforcement, over the objections of state governors.
“If the corrupt politicians of Minnesota don’t obey the law and stop the professional agitators and insurrectionists from attacking the Patriots of I.C.E., who are only trying to do their job, I will institute the INSURRECTION ACT, which many Presidents have done before me, and quickly put an end to the travesty that is taking place in that once great State,” Trump said in social media post.
The Associated Press has reached out to the offices of Gov. Tim Walz and Minneapolis Mayor Jacob Frey for comment.
The Department of Homeland Security says it has made more than 2,000 arrests in the state since early December and is vowing to not back down. ICE is a DHS agency.
In Minneapolis, smoke filled the streets Wednesday night near the site of the latest shooting as federal officers wearing gas masks and helmets fired tear gas into a small crowd. Protesters responded by throwing rocks and shooting fireworks.
Police Chief Brian O’Hara said during a news conference that the gathering was an unlawful assembly and “people need to leave.”
Things later quietened down and by early Thursday only a few demonstrators and law enforcement officers remained at the scene.
Demonstrations have become common on the streets of Minneapolis since the ICE agent fatally shot 37-year-old Good on Jan. 7. Agents have yanked people from their cars and homes, and have been confronted by angry bystanders demanding that the officers pack up and leave.
Minneapolis Mayor Jacob Frey described the situation as not “sustainable.”
“This is an impossible situation that our city is presently being put in and at the same time we are trying to find a way forward to keep people safe, to protect our neighbors, to maintain order,” he said.
Frey said the federal force — five times the size of the city’s 600-officer police force — has “invaded” Minneapolis, scaring and angering residents.
In a statement describing the events that led to Wednesday's shooting, Homeland Security said federal law enforcement officers stopped a driver from Venezuela who is in the U.S. illegally. The person drove away and crashed into a parked car before taking off on foot, DHS said.
After officers reached the person, two other people arrived from a nearby apartment and all three started attacking the officer, according to DHS.
“Fearing for his life and safety as he was being ambushed by three individuals, the officer fired a defensive shot to defend his life,” DHS said.
The two people who came out of the apartment are in custody, it said.
O’Hara said the man shot was in the hospital with a non-life-threatening injury.
The shooting took place about 4.5 miles (7.2 kilometers) north of where Good was killed. O’Hara's account of what happened largely echoed that of Homeland Security.
During a speech before the latest shooting, Walz described Minnesota as being in chaos, saying what's happening in the state “defies belief.”
“Let’s be very, very clear, this long ago stopped being a matter of immigration enforcement,” he said. “Instead, it’s a campaign of organized brutality against the people of Minnesota by our own federal government.”
Jonathan Ross, the Immigration and Customs Enforcement officer who killed Good, suffered internal bleeding to his torso during the encounter, a Homeland Security official told The Associated Press.
The official spoke to AP on condition of anonymity in order to discuss Ross’ medical condition. The official did not provide details about the severity of the injuries, and the agency did not respond to questions about the extent of the bleeding, exactly how he suffered the injury, when it was diagnosed or his medical treatment.
Good was killed after three ICE officers surrounded her SUV on a snowy street a few blocks from her home.
Bystander video shows one officer ordering Good to open the door and grabbing the handle. As the vehicle begins to move forward, Ross, standing in front, raises his weapon and fires at least three shots at close range. He steps back as the SUV advances and turns.
Homeland Security Secretary Kristi Noem has said Ross was struck by the vehicle and that Good was using her SUV as a weapon — a self-defense claim that has been criticized by Minnesota officials.
Chris Madel, an attorney for Ross, declined to comment.
Good’s family has hired the same law firm that represented George Floyd’s family in a $27 million settlement with Minneapolis. Floyd, who was Black, died after a white police officer pinned his neck to the ground in the street in May 2020.
Madhani reported from Washington, D.C. Associated Press reporters Julie Watson in San Diego; Rebecca Santana in Washington; Ed White in Detroit and Giovanna Dell’Orto in Minneapolis contributed.
A protester yells in front of law enforcement after a shooting on Wednesday, Jan. 14, 2026, in Minneapolis. (AP Photo/John Locher)
Tear gas surrounds federal law enforcement officers as they leave a scene after a shooting on Wednesday, Jan. 14, 2026, in Minneapolis. (AP Photo/John Locher)
Protesters shout at law enforcement officers after a shooting on Wednesday, Jan. 14, 2026, in Minneapolis. (AP Photo/Abbie Parr)
Law enforcement officers stand amid tear gas at the scene of a reported shooting Wednesday, Jan. 14, 2026, in Minneapolis. (AP Photo/Adam Gray)
